Alglucerase
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171972This classification denotes an enzyme replacement preparation with the molecular formula C2532H3854N672O711S16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 27T56C7KK0, more generally known as alglucerase. European Medicines Agency schedules alglucerase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05322MIG. The term ALGLUCERASE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, no3, 1993, list 33. ALGLUCERASE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Alglucerase under HS 35079090 and SITC 51691. SMILES:. As of Q4 2014, ALGLUCERASE remains the US FDA Preferred Term for this commodity. . Alglucerase bears US NLM identifiers UMLS ID C0102139 and NCI Concept Code C74208.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.